Gad Perry profile picture

Contact Information

Gad Perry, MD,FRCPC
613-737-7700 ext 25395


Selected Publications

Real-time measurement of urethral dose and position during permanent seed implantation for prostate brachytherapy. Cherpak A, Cygler J, E C, Perry G. Brachytherapy Journal 2014 Mar-Apr;13(2):169-77

A phase III trial comparing whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone versus WBRT with temozolomide (TMZ) or erlotinib for non-small cell lung cancer (NSCLC) and 1-3 brain metastases. Sperduto Paul W, Wang Meihua, Robins H. Ian, Schell Michael C, Werner-Wasik Maria, Komaki Ritsuko U, Souhami Luis, Buyounouski Mark K, Khuntia Deepak, Demas William F, Shah Sunjay A, Nedzi Lucien A, Perry GA, Suh John H, Mehta Minesh H.  International Journal of Radiation Oncology Biology Physics. 2013 April 1; 85(5):1312-1318

Twenty-four-month post radiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial. Crook JM, Malone S, Perry G, Eapen L, Owen J, Robertson S, Ludgate C, Fung S, Lockwood G. Cancer. 2009 Feb 1; 115(3):673-9.

Final report of a multicenter Canadian phase III randomized trial of 3 months vs.8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer. Crook J, Ludgate C, Malone S, Lim J, Perry G, Eapen L, Bowen J, Robertson S, Lockwood G. International Journal of Radiation Oncology Biology Physics. 2009 Feb 1;73(2):327-33.

Feasibility study of using MOSFET detectors for in-vivo dosimetry during permanent low-dose-rate prostate implants. Cygler J, Saoudi A, Perry G, Morash C, E C. Radiotherapy and Oncology 2006; 80(3):296-301.